LIVN LivaNova PLC

  1. Stocks
  2. Healthcare
  3. NASDAQ: LIVN

Price (delayed)

$77.54

Market cap

$3.77B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.29

Enterprise value

$4.23B

Sector: Healthcare
Industry: Medical Devices
Website: http://www.livanova.com/home.action

Highlights

LivaNova's quick ratio has surged by 119% YoY but it has decreased by 4.5% QoQ
The net income is down by 29% from the previous quarter but it is up by 6% YoY
LIVN's debt has soared by 80% year-on-year
LivaNova's revenue has decreased by 13% YoY and by 2.9% from the previous quarter

Key stats

What are the main financial stats of LIVN
Market
Shares outstanding
48.6M
Market cap
$3.77B
Enterprise value
$4.23B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.79
Price to sales (P/S)
3.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.45
Earnings
Revenue
$952.28M
EBIT
-$167.72M
EBITDA
-$85.13M
Free cash flow
-$149.88M
Per share
EPS
-$4.29
Free cash flow per share
-$3.08
Book value per share
$27.76
Revenue per share
$19.57
TBVPS
$20.95
Balance sheet
Total assets
$2.52B
Total liabilities
$1.17B
Debt
$694.19M
Equity
$1.35B
Working capital
$391.38M
Liquidity
Debt to equity
0.51
Current ratio
2.39
Quick ratio
1.49
Net debt/EBITDA
-5.48
Margins
EBITDA margin
-8.9%
Gross margin
68.3%
Net margin
-21.9%
Operating margin
-17.4%
Efficiency
Return on assets
-8.4%
Return on equity
-15.3%
Return on invested capital
-16.7%
Return on capital employed
-7.5%
Return on sales
-17.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LIVN stock price

How has the LivaNova stock price performed over time
Intraday
1.1%
1 week
10.47%
1 month
17.25%
1 year
23.67%
YTD
17.11%
QTD
17.11%

Financial performance

How have LivaNova's revenue and profit performed over time
Revenue
$952.28M
Gross profit
$650.3M
Operating income
-$166.11M
Net income
-$208.41M
Gross margin
68.3%
Net margin
-21.9%
The company's operating income rose by 45% YoY but it fell by 25% QoQ
LivaNova's operating margin has increased by 37% YoY but it has decreased by 29% QoQ
LIVN's net margin is down by 33% since the previous quarter and by 8% year-on-year
The net income is down by 29% from the previous quarter but it is up by 6% YoY

Growth

What is LivaNova's growth rate over time

Valuation

What is LivaNova stock price valuation
P/E
N/A
P/B
2.79
P/S
3.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.45
LivaNova's EPS has decreased by 29% QoQ but it has increased by 7% YoY
The price to book (P/B) is 47% higher than the last 4 quarters average of 1.9 and 33% higher than the 5-year quarterly average of 2.1
The equity has declined by 10% year-on-year
The price to sales (P/S) is 58% higher than the last 4 quarters average of 2.5 and 16% higher than the 5-year quarterly average of 3.4
LivaNova's revenue has decreased by 13% YoY and by 2.9% from the previous quarter

Efficiency

How efficient is LivaNova business performance
The ROIC has soared by 70% YoY but it has contracted by 7% from the previous quarter
LivaNova's return on sales has increased by 36% YoY but it has decreased by 26% QoQ
The return on equity has declined by 33% since the previous quarter and by 2.7% year-on-year
The company's return on assets fell by 29% QoQ but it rose by 3.4% YoY

Dividends

What is LIVN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LIVN.

Financial health

How did LivaNova financials performed over time
The company's total assets is 115% higher than its total liabilities
LivaNova's quick ratio has surged by 119% YoY but it has decreased by 4.5% QoQ
The current ratio has surged by 104% year-on-year but it has declined by 4.8% since the previous quarter
LIVN's debt is 49% smaller than its equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.